ENDOCRINE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184080, encodeId=993721840805e, content=偏重的研究方向：甲状腺 经验分享：2024.1.25 editor appointed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Fri Jan 26 11:40:47 CST 2024, time=2024-01-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189418, encodeId=64d7218941826, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：期刊转投，副主编和独立审稿人各一个审稿。 23.11.13 submit 23.11.15 with editor 23.11.16 under review 23.11.17 under review（审稿人接受审稿） 23.12.17 under review（第一个审稿意见） 23.12.19 under review（第二个审稿人） 24.1.19 required reviews completed（第二个审稿意见） 24.1.21 decision in process 24.1.22 major revision 24.2.2 revision submit 24.2.3 with editor 24.2.4 under review 24.2.5 required reviews completed / decision in process 24.2.6 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21888273920, createdName=ms5000000066723286, createdTime=Mon Feb 26 11:07:51 CST 2024, time=2024-02-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2155917, encodeId=ec3d215591e1a, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：内分泌 经验分享：感觉主编权力挺大的，人也很好，不刁钻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee5f5492890, createdName=ms3000000565671099, createdTime=Sun Sep 03 21:01:23 CST 2023, time=2023-09-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1010892, encodeId=03d31010892fe, content=我现在已经投稿了快60天，一直显示Under Review，老天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=216f5404986, createdName=张晗玉, createdTime=Tue Aug 24 09:55:33 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469956, encodeId=d68846995630, content=这个杂志分数不高，老板与主编还认识，几乎成为我们的实验室专业户了。 Gong H, Tang Z, Yang Y, Sun L, Zhang W, Wang W, Cui B, Ning G. A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene. Endocrine. 2008 Jun;33(3):230-4. Wang S, Mao C, Zhao Z, Gu Q, Jin M, Xiao Y, Jiang X, Zhao Y, Zhang Y, Ning G. Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves' disease. Endocrine. 2009 Aug;36(1):119-25. Zhang YW, Jia HY, Hong J, Ge Y, Zhang HJ, Shen CF, Ye L, Cui B, Li XY, Gu WQ, Zhang YF, Wang WQ, Ning G. Clinical and genetic analysis for four Chinese families with Prader-Willi syndrome. Endocrine. 2009 Aug;36(1):37-44. 我们总结下来，用基础研究的方法做临床，就基本没问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=endocrine, createdTime=Sun Dec 27 13:42:00 CST 2009, time=2009-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948418, encodeId=1f369484189d, content=请教下各位大牛，这个杂志接受case report吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/06/22/955285ad29e07b5358f172a75e45a208.jpg, createdBy=33112078860, createdName=136****8751, createdTime=Mon Mar 15 17:20:46 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092268, encodeId=6da12092268e2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：5.29投稿，6.28大修，8.31修回（返修时因为拖延耽误了点时间），10.3接受，编辑和审稿人都很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32766444405, createdName=ms1000000562543696, createdTime=Fri Oct 07 12:48:53 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119166, encodeId=993b211916610, content=虽然没被接收，但仍然要给这个杂志一个好评，审稿速度快，而且就算拒稿也会给出建设性意见，推荐～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e88440897, createdName=ms7000001469871773, createdTime=Mon Mar 13 09:15:31 CST 2023, time=2023-03-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=549284, encodeId=486754928404, content=审稿速度:1.0 经验分享：Required Reviews Completed 一周了，昨天还更新了一次时间，心情忐忑......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88652128473, createdName=啊呜啊喵, createdTime=Fri Nov 17 19:05:00 CST 2017, time=2017-11-17, status=1, ipAttribution=)]

2021-03-16 ms1000001155806208

求该期刊的参考文献格式，谢谢！

70 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184080, encodeId=993721840805e, content=偏重的研究方向：甲状腺 经验分享：2024.1.25 editor appointed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Fri Jan 26 11:40:47 CST 2024, time=2024-01-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189418, encodeId=64d7218941826, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：期刊转投，副主编和独立审稿人各一个审稿。 23.11.13 submit 23.11.15 with editor 23.11.16 under review 23.11.17 under review（审稿人接受审稿） 23.12.17 under review（第一个审稿意见） 23.12.19 under review（第二个审稿人） 24.1.19 required reviews completed（第二个审稿意见） 24.1.21 decision in process 24.1.22 major revision 24.2.2 revision submit 24.2.3 with editor 24.2.4 under review 24.2.5 required reviews completed / decision in process 24.2.6 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21888273920, createdName=ms5000000066723286, createdTime=Mon Feb 26 11:07:51 CST 2024, time=2024-02-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2155917, encodeId=ec3d215591e1a, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：内分泌 经验分享：感觉主编权力挺大的，人也很好，不刁钻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee5f5492890, createdName=ms3000000565671099, createdTime=Sun Sep 03 21:01:23 CST 2023, time=2023-09-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1010892, encodeId=03d31010892fe, content=我现在已经投稿了快60天，一直显示Under Review，老天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=216f5404986, createdName=张晗玉, createdTime=Tue Aug 24 09:55:33 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469956, encodeId=d68846995630, content=这个杂志分数不高，老板与主编还认识，几乎成为我们的实验室专业户了。 Gong H, Tang Z, Yang Y, Sun L, Zhang W, Wang W, Cui B, Ning G. A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene. Endocrine. 2008 Jun;33(3):230-4. Wang S, Mao C, Zhao Z, Gu Q, Jin M, Xiao Y, Jiang X, Zhao Y, Zhang Y, Ning G. Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves' disease. Endocrine. 2009 Aug;36(1):119-25. Zhang YW, Jia HY, Hong J, Ge Y, Zhang HJ, Shen CF, Ye L, Cui B, Li XY, Gu WQ, Zhang YF, Wang WQ, Ning G. Clinical and genetic analysis for four Chinese families with Prader-Willi syndrome. Endocrine. 2009 Aug;36(1):37-44. 我们总结下来，用基础研究的方法做临床，就基本没问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=endocrine, createdTime=Sun Dec 27 13:42:00 CST 2009, time=2009-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948418, encodeId=1f369484189d, content=请教下各位大牛，这个杂志接受case report吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/06/22/955285ad29e07b5358f172a75e45a208.jpg, createdBy=33112078860, createdName=136****8751, createdTime=Mon Mar 15 17:20:46 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092268, encodeId=6da12092268e2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：5.29投稿，6.28大修，8.31修回（返修时因为拖延耽误了点时间），10.3接受，编辑和审稿人都很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32766444405, createdName=ms1000000562543696, createdTime=Fri Oct 07 12:48:53 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119166, encodeId=993b211916610, content=虽然没被接收，但仍然要给这个杂志一个好评，审稿速度快，而且就算拒稿也会给出建设性意见，推荐～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e88440897, createdName=ms7000001469871773, createdTime=Mon Mar 13 09:15:31 CST 2023, time=2023-03-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=549284, encodeId=486754928404, content=审稿速度:1.0 经验分享：Required Reviews Completed 一周了，昨天还更新了一次时间，心情忐忑......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88652128473, createdName=啊呜啊喵, createdTime=Fri Nov 17 19:05:00 CST 2017, time=2017-11-17, status=1, ipAttribution=)]

2024-01-26 水逆退散～来自广西

偏重的研究方向：甲状腺
经验分享：2024.1.25 editor appointed

22 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184080, encodeId=993721840805e, content=偏重的研究方向：甲状腺 经验分享：2024.1.25 editor appointed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Fri Jan 26 11:40:47 CST 2024, time=2024-01-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189418, encodeId=64d7218941826, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：期刊转投，副主编和独立审稿人各一个审稿。 23.11.13 submit 23.11.15 with editor 23.11.16 under review 23.11.17 under review（审稿人接受审稿） 23.12.17 under review（第一个审稿意见） 23.12.19 under review（第二个审稿人） 24.1.19 required reviews completed（第二个审稿意见） 24.1.21 decision in process 24.1.22 major revision 24.2.2 revision submit 24.2.3 with editor 24.2.4 under review 24.2.5 required reviews completed / decision in process 24.2.6 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21888273920, createdName=ms5000000066723286, createdTime=Mon Feb 26 11:07:51 CST 2024, time=2024-02-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2155917, encodeId=ec3d215591e1a, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：内分泌 经验分享：感觉主编权力挺大的，人也很好，不刁钻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee5f5492890, createdName=ms3000000565671099, createdTime=Sun Sep 03 21:01:23 CST 2023, time=2023-09-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1010892, encodeId=03d31010892fe, content=我现在已经投稿了快60天，一直显示Under Review，老天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=216f5404986, createdName=张晗玉, createdTime=Tue Aug 24 09:55:33 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469956, encodeId=d68846995630, content=这个杂志分数不高，老板与主编还认识，几乎成为我们的实验室专业户了。 Gong H, Tang Z, Yang Y, Sun L, Zhang W, Wang W, Cui B, Ning G. A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene. Endocrine. 2008 Jun;33(3):230-4. Wang S, Mao C, Zhao Z, Gu Q, Jin M, Xiao Y, Jiang X, Zhao Y, Zhang Y, Ning G. Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves' disease. Endocrine. 2009 Aug;36(1):119-25. Zhang YW, Jia HY, Hong J, Ge Y, Zhang HJ, Shen CF, Ye L, Cui B, Li XY, Gu WQ, Zhang YF, Wang WQ, Ning G. Clinical and genetic analysis for four Chinese families with Prader-Willi syndrome. Endocrine. 2009 Aug;36(1):37-44. 我们总结下来，用基础研究的方法做临床，就基本没问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=endocrine, createdTime=Sun Dec 27 13:42:00 CST 2009, time=2009-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948418, encodeId=1f369484189d, content=请教下各位大牛，这个杂志接受case report吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/06/22/955285ad29e07b5358f172a75e45a208.jpg, createdBy=33112078860, createdName=136****8751, createdTime=Mon Mar 15 17:20:46 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092268, encodeId=6da12092268e2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：5.29投稿，6.28大修，8.31修回（返修时因为拖延耽误了点时间），10.3接受，编辑和审稿人都很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32766444405, createdName=ms1000000562543696, createdTime=Fri Oct 07 12:48:53 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119166, encodeId=993b211916610, content=虽然没被接收，但仍然要给这个杂志一个好评，审稿速度快，而且就算拒稿也会给出建设性意见，推荐～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e88440897, createdName=ms7000001469871773, createdTime=Mon Mar 13 09:15:31 CST 2023, time=2023-03-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=549284, encodeId=486754928404, content=审稿速度:1.0 经验分享：Required Reviews Completed 一周了，昨天还更新了一次时间，心情忐忑......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88652128473, createdName=啊呜啊喵, createdTime=Fri Nov 17 19:05:00 CST 2017, time=2017-11-17, status=1, ipAttribution=)]

2024-02-26 ms5000000066723286 来自江苏省

审稿速度:1.0
偏重的研究方向：糖尿病
经验分享：期刊转投，副主编和独立审稿人各一个审稿。 23.11.13 submit 23.11.15 with editor 23.11.16 under review 23.11.17 under review（审稿人接受审稿） 23.12.17 under review（第一个审稿意见） 23.12.19 under review（第二个审稿人） 24.1.19 required reviews completed（第二个审稿意见） 24.1.21 decision in process 24.1.22 major revision 24.2.2 revision submit 24.2.3 with editor 24.2.4 under review 24.2.5 required reviews completed / decision in process 24.2.6 accept

47 0

[GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184080, encodeId=993721840805e, content=偏重的研究方向：甲状腺 经验分享：2024.1.25 editor appointed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Fri Jan 26 11:40:47 CST 2024, time=2024-01-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189418, encodeId=64d7218941826, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：期刊转投，副主编和独立审稿人各一个审稿。 23.11.13 submit 23.11.15 with editor 23.11.16 under review 23.11.17 under review（审稿人接受审稿） 23.12.17 under review（第一个审稿意见） 23.12.19 under review（第二个审稿人） 24.1.19 required reviews completed（第二个审稿意见） 24.1.21 decision in process 24.1.22 major revision 24.2.2 revision submit 24.2.3 with editor 24.2.4 under review 24.2.5 required reviews completed / decision in process 24.2.6 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21888273920, createdName=ms5000000066723286, createdTime=Mon Feb 26 11:07:51 CST 2024, time=2024-02-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2155917, encodeId=ec3d215591e1a, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：内分泌 经验分享：感觉主编权力挺大的，人也很好，不刁钻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee5f5492890, createdName=ms3000000565671099, createdTime=Sun Sep 03 21:01:23 CST 2023, time=2023-09-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1010892, encodeId=03d31010892fe, content=我现在已经投稿了快60天，一直显示Under Review，老天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=216f5404986, createdName=张晗玉, createdTime=Tue Aug 24 09:55:33 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469956, encodeId=d68846995630, content=这个杂志分数不高，老板与主编还认识，几乎成为我们的实验室专业户了。 Gong H, Tang Z, Yang Y, Sun L, Zhang W, Wang W, Cui B, Ning G. A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene. Endocrine. 2008 Jun;33(3):230-4. Wang S, Mao C, Zhao Z, Gu Q, Jin M, Xiao Y, Jiang X, Zhao Y, Zhang Y, Ning G. Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves' disease. Endocrine. 2009 Aug;36(1):119-25. Zhang YW, Jia HY, Hong J, Ge Y, Zhang HJ, Shen CF, Ye L, Cui B, Li XY, Gu WQ, Zhang YF, Wang WQ, Ning G. Clinical and genetic analysis for four Chinese families with Prader-Willi syndrome. Endocrine. 2009 Aug;36(1):37-44. 我们总结下来，用基础研究的方法做临床，就基本没问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=endocrine, createdTime=Sun Dec 27 13:42:00 CST 2009, time=2009-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948418, encodeId=1f369484189d, content=请教下各位大牛，这个杂志接受case report吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/06/22/955285ad29e07b5358f172a75e45a208.jpg, createdBy=33112078860, createdName=136****8751, createdTime=Mon Mar 15 17:20:46 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092268, encodeId=6da12092268e2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：5.29投稿，6.28大修，8.31修回（返修时因为拖延耽误了点时间），10.3接受，编辑和审稿人都很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32766444405, createdName=ms1000000562543696, createdTime=Fri Oct 07 12:48:53 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119166, encodeId=993b211916610, content=虽然没被接收，但仍然要给这个杂志一个好评，审稿速度快，而且就算拒稿也会给出建设性意见，推荐～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e88440897, createdName=ms7000001469871773, createdTime=Mon Mar 13 09:15:31 CST 2023, time=2023-03-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=549284, encodeId=486754928404, content=审稿速度:1.0 经验分享：Required Reviews Completed 一周了，昨天还更新了一次时间，心情忐忑......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88652128473, createdName=啊呜啊喵, createdTime=Fri Nov 17 19:05:00 CST 2017, time=2017-11-17, status=1, ipAttribution=)]

2023-09-03 ms3000000565671099 来自广东省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：内分泌
经验分享：感觉主编权力挺大的，人也很好，不刁钻

35 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184080, encodeId=993721840805e, content=偏重的研究方向：甲状腺 经验分享：2024.1.25 editor appointed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Fri Jan 26 11:40:47 CST 2024, time=2024-01-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189418, encodeId=64d7218941826, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：期刊转投，副主编和独立审稿人各一个审稿。 23.11.13 submit 23.11.15 with editor 23.11.16 under review 23.11.17 under review（审稿人接受审稿） 23.12.17 under review（第一个审稿意见） 23.12.19 under review（第二个审稿人） 24.1.19 required reviews completed（第二个审稿意见） 24.1.21 decision in process 24.1.22 major revision 24.2.2 revision submit 24.2.3 with editor 24.2.4 under review 24.2.5 required reviews completed / decision in process 24.2.6 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21888273920, createdName=ms5000000066723286, createdTime=Mon Feb 26 11:07:51 CST 2024, time=2024-02-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2155917, encodeId=ec3d215591e1a, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：内分泌 经验分享：感觉主编权力挺大的，人也很好，不刁钻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee5f5492890, createdName=ms3000000565671099, createdTime=Sun Sep 03 21:01:23 CST 2023, time=2023-09-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1010892, encodeId=03d31010892fe, content=我现在已经投稿了快60天，一直显示Under Review，老天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=216f5404986, createdName=张晗玉, createdTime=Tue Aug 24 09:55:33 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469956, encodeId=d68846995630, content=这个杂志分数不高，老板与主编还认识，几乎成为我们的实验室专业户了。 Gong H, Tang Z, Yang Y, Sun L, Zhang W, Wang W, Cui B, Ning G. A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene. Endocrine. 2008 Jun;33(3):230-4. Wang S, Mao C, Zhao Z, Gu Q, Jin M, Xiao Y, Jiang X, Zhao Y, Zhang Y, Ning G. Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves' disease. Endocrine. 2009 Aug;36(1):119-25. Zhang YW, Jia HY, Hong J, Ge Y, Zhang HJ, Shen CF, Ye L, Cui B, Li XY, Gu WQ, Zhang YF, Wang WQ, Ning G. Clinical and genetic analysis for four Chinese families with Prader-Willi syndrome. Endocrine. 2009 Aug;36(1):37-44. 我们总结下来，用基础研究的方法做临床，就基本没问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=endocrine, createdTime=Sun Dec 27 13:42:00 CST 2009, time=2009-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948418, encodeId=1f369484189d, content=请教下各位大牛，这个杂志接受case report吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/06/22/955285ad29e07b5358f172a75e45a208.jpg, createdBy=33112078860, createdName=136****8751, createdTime=Mon Mar 15 17:20:46 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092268, encodeId=6da12092268e2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：5.29投稿，6.28大修，8.31修回（返修时因为拖延耽误了点时间），10.3接受，编辑和审稿人都很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32766444405, createdName=ms1000000562543696, createdTime=Fri Oct 07 12:48:53 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119166, encodeId=993b211916610, content=虽然没被接收，但仍然要给这个杂志一个好评，审稿速度快，而且就算拒稿也会给出建设性意见，推荐～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e88440897, createdName=ms7000001469871773, createdTime=Mon Mar 13 09:15:31 CST 2023, time=2023-03-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=549284, encodeId=486754928404, content=审稿速度:1.0 经验分享：Required Reviews Completed 一周了，昨天还更新了一次时间，心情忐忑......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88652128473, createdName=啊呜啊喵, createdTime=Fri Nov 17 19:05:00 CST 2017, time=2017-11-17, status=1, ipAttribution=)]

2021-08-24 张晗玉

我现在已经投稿了快60天，一直显示Under Review，老天啊

86 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184080, encodeId=993721840805e, content=偏重的研究方向：甲状腺 经验分享：2024.1.25 editor appointed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Fri Jan 26 11:40:47 CST 2024, time=2024-01-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189418, encodeId=64d7218941826, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：期刊转投，副主编和独立审稿人各一个审稿。 23.11.13 submit 23.11.15 with editor 23.11.16 under review 23.11.17 under review（审稿人接受审稿） 23.12.17 under review（第一个审稿意见） 23.12.19 under review（第二个审稿人） 24.1.19 required reviews completed（第二个审稿意见） 24.1.21 decision in process 24.1.22 major revision 24.2.2 revision submit 24.2.3 with editor 24.2.4 under review 24.2.5 required reviews completed / decision in process 24.2.6 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21888273920, createdName=ms5000000066723286, createdTime=Mon Feb 26 11:07:51 CST 2024, time=2024-02-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2155917, encodeId=ec3d215591e1a, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：内分泌 经验分享：感觉主编权力挺大的，人也很好，不刁钻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee5f5492890, createdName=ms3000000565671099, createdTime=Sun Sep 03 21:01:23 CST 2023, time=2023-09-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1010892, encodeId=03d31010892fe, content=我现在已经投稿了快60天，一直显示Under Review，老天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=216f5404986, createdName=张晗玉, createdTime=Tue Aug 24 09:55:33 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469956, encodeId=d68846995630, content=这个杂志分数不高，老板与主编还认识，几乎成为我们的实验室专业户了。 Gong H, Tang Z, Yang Y, Sun L, Zhang W, Wang W, Cui B, Ning G. A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene. Endocrine. 2008 Jun;33(3):230-4. Wang S, Mao C, Zhao Z, Gu Q, Jin M, Xiao Y, Jiang X, Zhao Y, Zhang Y, Ning G. Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves' disease. Endocrine. 2009 Aug;36(1):119-25. Zhang YW, Jia HY, Hong J, Ge Y, Zhang HJ, Shen CF, Ye L, Cui B, Li XY, Gu WQ, Zhang YF, Wang WQ, Ning G. Clinical and genetic analysis for four Chinese families with Prader-Willi syndrome. Endocrine. 2009 Aug;36(1):37-44. 我们总结下来，用基础研究的方法做临床，就基本没问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=endocrine, createdTime=Sun Dec 27 13:42:00 CST 2009, time=2009-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948418, encodeId=1f369484189d, content=请教下各位大牛，这个杂志接受case report吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/06/22/955285ad29e07b5358f172a75e45a208.jpg, createdBy=33112078860, createdName=136****8751, createdTime=Mon Mar 15 17:20:46 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092268, encodeId=6da12092268e2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：5.29投稿，6.28大修，8.31修回（返修时因为拖延耽误了点时间），10.3接受，编辑和审稿人都很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32766444405, createdName=ms1000000562543696, createdTime=Fri Oct 07 12:48:53 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119166, encodeId=993b211916610, content=虽然没被接收，但仍然要给这个杂志一个好评，审稿速度快，而且就算拒稿也会给出建设性意见，推荐～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e88440897, createdName=ms7000001469871773, createdTime=Mon Mar 13 09:15:31 CST 2023, time=2023-03-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=549284, encodeId=486754928404, content=审稿速度:1.0 经验分享：Required Reviews Completed 一周了，昨天还更新了一次时间，心情忐忑......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88652128473, createdName=啊呜啊喵, createdTime=Fri Nov 17 19:05:00 CST 2017, time=2017-11-17, status=1, ipAttribution=)]

2009-12-27 endocrine

这个杂志分数不高，老板与主编还认识，几乎成为我们的实验室专业户了。

Gong H, Tang Z, Yang Y, Sun L, Zhang W, Wang W, Cui B, Ning G. A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene. Endocrine. 2008 Jun;33(3):230-4.

Wang S, Mao C, Zhao Z, Gu Q, Jin M, Xiao Y, Jiang X, Zhao Y, Zhang Y, Ning G. Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves' disease. Endocrine. 2009 Aug;36(1):119-25.

Zhang YW, Jia HY, Hong J, Ge Y, Zhang HJ, Shen CF, Ye L, Cui B, Li XY, Gu WQ, Zhang YF, Wang WQ, Ning G. Clinical and genetic analysis for four Chinese families with Prader-Willi syndrome. Endocrine. 2009 Aug;36(1):37-44.
我们总结下来，用基础研究的方法做临床，就基本没问题。

316 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184080, encodeId=993721840805e, content=偏重的研究方向：甲状腺 经验分享：2024.1.25 editor appointed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Fri Jan 26 11:40:47 CST 2024, time=2024-01-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189418, encodeId=64d7218941826, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：期刊转投，副主编和独立审稿人各一个审稿。 23.11.13 submit 23.11.15 with editor 23.11.16 under review 23.11.17 under review（审稿人接受审稿） 23.12.17 under review（第一个审稿意见） 23.12.19 under review（第二个审稿人） 24.1.19 required reviews completed（第二个审稿意见） 24.1.21 decision in process 24.1.22 major revision 24.2.2 revision submit 24.2.3 with editor 24.2.4 under review 24.2.5 required reviews completed / decision in process 24.2.6 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21888273920, createdName=ms5000000066723286, createdTime=Mon Feb 26 11:07:51 CST 2024, time=2024-02-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2155917, encodeId=ec3d215591e1a, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：内分泌 经验分享：感觉主编权力挺大的，人也很好，不刁钻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee5f5492890, createdName=ms3000000565671099, createdTime=Sun Sep 03 21:01:23 CST 2023, time=2023-09-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1010892, encodeId=03d31010892fe, content=我现在已经投稿了快60天，一直显示Under Review，老天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=216f5404986, createdName=张晗玉, createdTime=Tue Aug 24 09:55:33 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469956, encodeId=d68846995630, content=这个杂志分数不高，老板与主编还认识，几乎成为我们的实验室专业户了。 Gong H, Tang Z, Yang Y, Sun L, Zhang W, Wang W, Cui B, Ning G. A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene. Endocrine. 2008 Jun;33(3):230-4. Wang S, Mao C, Zhao Z, Gu Q, Jin M, Xiao Y, Jiang X, Zhao Y, Zhang Y, Ning G. Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves' disease. Endocrine. 2009 Aug;36(1):119-25. Zhang YW, Jia HY, Hong J, Ge Y, Zhang HJ, Shen CF, Ye L, Cui B, Li XY, Gu WQ, Zhang YF, Wang WQ, Ning G. Clinical and genetic analysis for four Chinese families with Prader-Willi syndrome. Endocrine. 2009 Aug;36(1):37-44. 我们总结下来，用基础研究的方法做临床，就基本没问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=endocrine, createdTime=Sun Dec 27 13:42:00 CST 2009, time=2009-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948418, encodeId=1f369484189d, content=请教下各位大牛，这个杂志接受case report吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/06/22/955285ad29e07b5358f172a75e45a208.jpg, createdBy=33112078860, createdName=136****8751, createdTime=Mon Mar 15 17:20:46 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092268, encodeId=6da12092268e2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：5.29投稿，6.28大修，8.31修回（返修时因为拖延耽误了点时间），10.3接受，编辑和审稿人都很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32766444405, createdName=ms1000000562543696, createdTime=Fri Oct 07 12:48:53 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119166, encodeId=993b211916610, content=虽然没被接收，但仍然要给这个杂志一个好评，审稿速度快，而且就算拒稿也会给出建设性意见，推荐～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e88440897, createdName=ms7000001469871773, createdTime=Mon Mar 13 09:15:31 CST 2023, time=2023-03-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=549284, encodeId=486754928404, content=审稿速度:1.0 经验分享：Required Reviews Completed 一周了，昨天还更新了一次时间，心情忐忑......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88652128473, createdName=啊呜啊喵, createdTime=Fri Nov 17 19:05:00 CST 2017, time=2017-11-17, status=1, ipAttribution=)]

2021-03-15 136****8751

请教下各位大牛，这个杂志接受case report吗

87 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184080, encodeId=993721840805e, content=偏重的研究方向：甲状腺 经验分享：2024.1.25 editor appointed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Fri Jan 26 11:40:47 CST 2024, time=2024-01-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189418, encodeId=64d7218941826, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：期刊转投，副主编和独立审稿人各一个审稿。 23.11.13 submit 23.11.15 with editor 23.11.16 under review 23.11.17 under review（审稿人接受审稿） 23.12.17 under review（第一个审稿意见） 23.12.19 under review（第二个审稿人） 24.1.19 required reviews completed（第二个审稿意见） 24.1.21 decision in process 24.1.22 major revision 24.2.2 revision submit 24.2.3 with editor 24.2.4 under review 24.2.5 required reviews completed / decision in process 24.2.6 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21888273920, createdName=ms5000000066723286, createdTime=Mon Feb 26 11:07:51 CST 2024, time=2024-02-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2155917, encodeId=ec3d215591e1a, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：内分泌 经验分享：感觉主编权力挺大的，人也很好，不刁钻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee5f5492890, createdName=ms3000000565671099, createdTime=Sun Sep 03 21:01:23 CST 2023, time=2023-09-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1010892, encodeId=03d31010892fe, content=我现在已经投稿了快60天，一直显示Under Review，老天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=216f5404986, createdName=张晗玉, createdTime=Tue Aug 24 09:55:33 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469956, encodeId=d68846995630, content=这个杂志分数不高，老板与主编还认识，几乎成为我们的实验室专业户了。 Gong H, Tang Z, Yang Y, Sun L, Zhang W, Wang W, Cui B, Ning G. A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene. Endocrine. 2008 Jun;33(3):230-4. Wang S, Mao C, Zhao Z, Gu Q, Jin M, Xiao Y, Jiang X, Zhao Y, Zhang Y, Ning G. Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves' disease. Endocrine. 2009 Aug;36(1):119-25. Zhang YW, Jia HY, Hong J, Ge Y, Zhang HJ, Shen CF, Ye L, Cui B, Li XY, Gu WQ, Zhang YF, Wang WQ, Ning G. Clinical and genetic analysis for four Chinese families with Prader-Willi syndrome. Endocrine. 2009 Aug;36(1):37-44. 我们总结下来，用基础研究的方法做临床，就基本没问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=endocrine, createdTime=Sun Dec 27 13:42:00 CST 2009, time=2009-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948418, encodeId=1f369484189d, content=请教下各位大牛，这个杂志接受case report吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/06/22/955285ad29e07b5358f172a75e45a208.jpg, createdBy=33112078860, createdName=136****8751, createdTime=Mon Mar 15 17:20:46 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092268, encodeId=6da12092268e2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：5.29投稿，6.28大修，8.31修回（返修时因为拖延耽误了点时间），10.3接受，编辑和审稿人都很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32766444405, createdName=ms1000000562543696, createdTime=Fri Oct 07 12:48:53 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119166, encodeId=993b211916610, content=虽然没被接收，但仍然要给这个杂志一个好评，审稿速度快，而且就算拒稿也会给出建设性意见，推荐～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e88440897, createdName=ms7000001469871773, createdTime=Mon Mar 13 09:15:31 CST 2023, time=2023-03-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=549284, encodeId=486754928404, content=审稿速度:1.0 经验分享：Required Reviews Completed 一周了，昨天还更新了一次时间，心情忐忑......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88652128473, createdName=啊呜啊喵, createdTime=Fri Nov 17 19:05:00 CST 2017, time=2017-11-17, status=1, ipAttribution=)]

2022-10-07 ms1000000562543696

审稿速度:1.0 | 投稿命中率:50.0
经验分享：5.29投稿，6.28大修，8.31修回（返修时因为拖延耽误了点时间），10.3接受，编辑和审稿人都很友好

54 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184080, encodeId=993721840805e, content=偏重的研究方向：甲状腺 经验分享：2024.1.25 editor appointed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Fri Jan 26 11:40:47 CST 2024, time=2024-01-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189418, encodeId=64d7218941826, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：期刊转投，副主编和独立审稿人各一个审稿。 23.11.13 submit 23.11.15 with editor 23.11.16 under review 23.11.17 under review（审稿人接受审稿） 23.12.17 under review（第一个审稿意见） 23.12.19 under review（第二个审稿人） 24.1.19 required reviews completed（第二个审稿意见） 24.1.21 decision in process 24.1.22 major revision 24.2.2 revision submit 24.2.3 with editor 24.2.4 under review 24.2.5 required reviews completed / decision in process 24.2.6 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21888273920, createdName=ms5000000066723286, createdTime=Mon Feb 26 11:07:51 CST 2024, time=2024-02-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2155917, encodeId=ec3d215591e1a, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：内分泌 经验分享：感觉主编权力挺大的，人也很好，不刁钻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee5f5492890, createdName=ms3000000565671099, createdTime=Sun Sep 03 21:01:23 CST 2023, time=2023-09-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1010892, encodeId=03d31010892fe, content=我现在已经投稿了快60天，一直显示Under Review，老天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=216f5404986, createdName=张晗玉, createdTime=Tue Aug 24 09:55:33 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469956, encodeId=d68846995630, content=这个杂志分数不高，老板与主编还认识，几乎成为我们的实验室专业户了。 Gong H, Tang Z, Yang Y, Sun L, Zhang W, Wang W, Cui B, Ning G. A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene. Endocrine. 2008 Jun;33(3):230-4. Wang S, Mao C, Zhao Z, Gu Q, Jin M, Xiao Y, Jiang X, Zhao Y, Zhang Y, Ning G. Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves' disease. Endocrine. 2009 Aug;36(1):119-25. Zhang YW, Jia HY, Hong J, Ge Y, Zhang HJ, Shen CF, Ye L, Cui B, Li XY, Gu WQ, Zhang YF, Wang WQ, Ning G. Clinical and genetic analysis for four Chinese families with Prader-Willi syndrome. Endocrine. 2009 Aug;36(1):37-44. 我们总结下来，用基础研究的方法做临床，就基本没问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=endocrine, createdTime=Sun Dec 27 13:42:00 CST 2009, time=2009-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948418, encodeId=1f369484189d, content=请教下各位大牛，这个杂志接受case report吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/06/22/955285ad29e07b5358f172a75e45a208.jpg, createdBy=33112078860, createdName=136****8751, createdTime=Mon Mar 15 17:20:46 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092268, encodeId=6da12092268e2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：5.29投稿，6.28大修，8.31修回（返修时因为拖延耽误了点时间），10.3接受，编辑和审稿人都很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32766444405, createdName=ms1000000562543696, createdTime=Fri Oct 07 12:48:53 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119166, encodeId=993b211916610, content=虽然没被接收，但仍然要给这个杂志一个好评，审稿速度快，而且就算拒稿也会给出建设性意见，推荐～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e88440897, createdName=ms7000001469871773, createdTime=Mon Mar 13 09:15:31 CST 2023, time=2023-03-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=549284, encodeId=486754928404, content=审稿速度:1.0 经验分享：Required Reviews Completed 一周了，昨天还更新了一次时间，心情忐忑......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88652128473, createdName=啊呜啊喵, createdTime=Fri Nov 17 19:05:00 CST 2017, time=2017-11-17, status=1, ipAttribution=)]

2023-03-13 ms7000001469871773 来自山东省

虽然没被接收，但仍然要给这个杂志一个好评，审稿速度快，而且就算拒稿也会给出建设性意见，推荐～

50 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184080, encodeId=993721840805e, content=偏重的研究方向：甲状腺 经验分享：2024.1.25 editor appointed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Fri Jan 26 11:40:47 CST 2024, time=2024-01-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189418, encodeId=64d7218941826, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：期刊转投，副主编和独立审稿人各一个审稿。 23.11.13 submit 23.11.15 with editor 23.11.16 under review 23.11.17 under review（审稿人接受审稿） 23.12.17 under review（第一个审稿意见） 23.12.19 under review（第二个审稿人） 24.1.19 required reviews completed（第二个审稿意见） 24.1.21 decision in process 24.1.22 major revision 24.2.2 revision submit 24.2.3 with editor 24.2.4 under review 24.2.5 required reviews completed / decision in process 24.2.6 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21888273920, createdName=ms5000000066723286, createdTime=Mon Feb 26 11:07:51 CST 2024, time=2024-02-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2155917, encodeId=ec3d215591e1a, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：内分泌 经验分享：感觉主编权力挺大的，人也很好，不刁钻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee5f5492890, createdName=ms3000000565671099, createdTime=Sun Sep 03 21:01:23 CST 2023, time=2023-09-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1010892, encodeId=03d31010892fe, content=我现在已经投稿了快60天，一直显示Under Review，老天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=216f5404986, createdName=张晗玉, createdTime=Tue Aug 24 09:55:33 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469956, encodeId=d68846995630, content=这个杂志分数不高，老板与主编还认识，几乎成为我们的实验室专业户了。 Gong H, Tang Z, Yang Y, Sun L, Zhang W, Wang W, Cui B, Ning G. A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene. Endocrine. 2008 Jun;33(3):230-4. Wang S, Mao C, Zhao Z, Gu Q, Jin M, Xiao Y, Jiang X, Zhao Y, Zhang Y, Ning G. Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves' disease. Endocrine. 2009 Aug;36(1):119-25. Zhang YW, Jia HY, Hong J, Ge Y, Zhang HJ, Shen CF, Ye L, Cui B, Li XY, Gu WQ, Zhang YF, Wang WQ, Ning G. Clinical and genetic analysis for four Chinese families with Prader-Willi syndrome. Endocrine. 2009 Aug;36(1):37-44. 我们总结下来，用基础研究的方法做临床，就基本没问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=endocrine, createdTime=Sun Dec 27 13:42:00 CST 2009, time=2009-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948418, encodeId=1f369484189d, content=请教下各位大牛，这个杂志接受case report吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/06/22/955285ad29e07b5358f172a75e45a208.jpg, createdBy=33112078860, createdName=136****8751, createdTime=Mon Mar 15 17:20:46 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092268, encodeId=6da12092268e2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：5.29投稿，6.28大修，8.31修回（返修时因为拖延耽误了点时间），10.3接受，编辑和审稿人都很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32766444405, createdName=ms1000000562543696, createdTime=Fri Oct 07 12:48:53 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119166, encodeId=993b211916610, content=虽然没被接收，但仍然要给这个杂志一个好评，审稿速度快，而且就算拒稿也会给出建设性意见，推荐～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e88440897, createdName=ms7000001469871773, createdTime=Mon Mar 13 09:15:31 CST 2023, time=2023-03-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=549284, encodeId=486754928404, content=审稿速度:1.0 经验分享：Required Reviews Completed 一周了，昨天还更新了一次时间，心情忐忑......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88652128473, createdName=啊呜啊喵, createdTime=Fri Nov 17 19:05:00 CST 2017, time=2017-11-17, status=1, ipAttribution=)]

2017-11-17 啊呜啊喵

审稿速度:1.0
经验分享：Required Reviews Completed 一周了，昨天还更新了一次时间，心情忐忑......

356 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务